• 06 Dec 19

Executive interview - Heidelberg Pharma at EKF 2019

Executive interview - Heidelberg Pharma at EKF 2019

Wilex | WL6 | 0 0 0%
Follow Company Follow Company

    • 22 views

 

Enjoying this article?

Get a £25 credit by sharing with your friends and colleagues via the share buttons below. Each new subscriber gets a 10% discount and you get a free month off your bill every time.


Don't worry, if you're a Lite-Access/Free user we save all your credits for the day you decide to fully subscribe.


 

Executive Interview - Heidelberg Pharma

Companies: Wilex

Executive interview - InMed: A leader in the development of cannabinol (CBN) therapeutics

Companies: INMED PHARMACEUTICALS

Executive interview - InMed: Leading the way in the therapeutic development of cannabinol (CBN)

Companies: INMED PHARMACEUTICALS

Executive interview - InMed’s cannabinol (CBN) formulation for glaucoma

Companies: INMED PHARMACEUTICALS

Executive interview - InMed’s cannabinol (CBN) clinical program in epidermolysis bullosa

Companies: INMED PHARMACEUTICALS

Executive interview - InMed: Is cannabinol (CBN) safe?

Companies: INMED PHARMACEUTICALS

Copyright © 2020 Research Tree | All Rights Reserved. | Terms of Service and Privacy Policy and Statement on Cookies

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Tools licensed and contents implemented and optimized by Digital Look Ltd.

DigitalLook |Web Financial Group

©1999-2013 – Digital Look Ltd. A Web Financial Group Company All rights reserved. Legal notice.

Top